Thursday, July 8, 2021
COVID-19: Worst yet to come for Africa, says WHO
Wednesday, March 3, 2021
Kenya receives 1.02 million doses of COVID-19 vaccine
Over 1 million doses of Oxford-AstraZeneca vaccine part of 24 million doses country expects to receive within months
NAIROBI, Kenya — Kenya has received just over 1 million
doses of a COVID-19 vaccine in the first batch from the global COVAX initiative
that was created to ensure that low- and middle-income countries have fair
access to vaccines.
Some 1.02 million doses of the AstraZeneca-Oxford vaccine,
manufactured by the Serum Institute of India, arrived in Nairobi early
Wednesday, according to a joint statement from UNICEF, the World Health
Organization, international vaccine alliance GAVI and the Coalition for
Epidemic Preparedness Innovations.
Kenyan Health Minister Mutahi Kagwe expressed excitement and
optimism that the vaccines would help stop the spread of the coronavirus that
has forced the East African country to partially lock down its economy with
devastating consequences for many citizens.
“We have been fighting the pandemic with rubber bullets but
what we have acquired today is equivalent, metaphorically speaking, to bazookas
and machine guns,” Kagwe said.
The minister said the vaccines will be administered to some
400,000 medical workers and the rest will go to other frontline workers such as
teachers and police officers.
Many Kenyan public health care workers have been disgruntled
over the inadequate supply of personal protective equipment, and they say they
were never paid the allowances that the government promised them for the extra
work and risk while combating COVID-19.
Austine Oduor, an official with the Kenya Union of Clinical
Officers, said there is no palpable excitement from members of his union and
nurses who were forced by a court order to resume work last week after a 70-day
strike.
“What they really wanted was payment of the allowances,”
Oduor said. “ In fact, some are questioning whether the distribution will be
done fairly in a country where corruption is rampant.”
Kenya has more than 106,000 confirmed virus cases including
more than 1,800 deaths.
Sunday, February 7, 2021
WHO assures support for Nigeria on COVID-19 vaccines
The World Health Organization (WHO) has assured Nigeria that
it will support the country procure, distribute and administer COVID-19
vaccines.
Speaking during a press briefing in Nigeria’s capital Abuja
on Saturday, WHO Country Representative Walter Kazadi Mulomboo, said that
Nigeria and other Africa countries were not disqualified from accessing
COVID-19 vaccines through the COVAX facility, the WHO-led initiative for equitable
global access to coronavirus vaccines, to meet the urgent vaccination needs of
developing countries.
The assurance was in response to rumors that the WHO
disqualified Nigeria from COVID-19 vaccines based on the country’s inability to
meet the standard requirement of storing the vaccines at the required -70
degrees Celsius.
Earlier, senior Nigerian officials had noted that the
country was hoping to get more than 40 million COVID-19 vaccine doses to cover
one-fifth of its population through the global COVAX scheme in 2021.
According to Mulomboo, WHO is supporting all countries to
access the vaccines as quickly as possible, and all countries on the
continent are expected to start accessing the AstraZeneca/Oxford vaccine by the
end of February, noting that the vaccine is under WHO review for emergency use
listing, and the outcome is expected soon.
“Of all the 88 million AstraZeneca vaccine doses allocated
to African countries for the first phase, Nigeria has received by far the
largest allocation, with 16 million doses,” he said.
Also at the press briefing, Faisal Shuaib, director-general
of Nigeria’s National Primary Healthcare Development Agency (NPHDA), said that
several factors were considered in allocating the small quantity of vaccines in
the initial stage to COVAX countries.
These include the mortality rates from COVID-19, the number
of new cases, the trend in the number of cases, the population of countries,
and the availability of the appropriate cold chain equipment, Shuaib said.
The latest figures by the Nigeria Center for Disease Control
indicate that the country registered 1,588 new cases of COVID-19 on Saturday,
bringing the total number of infections in the country to 139,242 and total
deaths to 1,647.
Friday, December 4, 2020
Yellow fever claims 172 lives In Nigeria: WHO
![]() |
A yellow fever outbreak in Nigeria has
killed 172 people so far, the WHO said. - AFP/File |
A yellow fever outbreak in Nigeria has killed 172 people so far, the World Health Organisation (WHO) said Friday.
The outbreak poses an extra challenge to the
country's health system as Africa's most populous nation deals with the
Covid-19 pandemic, several concurrent disease outbreaks and a humanitarian
crisis in the northeast, the WHO said.
Nigeria has been battling successive yellow
fever outbreaks since 2017. This latest outbreak was detected in November, WHO
spokesman Tarik Jasarevic told reporters in Geneva.
"As of November 24, the outbreak has been
reported in five states in Nigeria: Delta, Enugu, Bauchi, Benue and
Ebonyi," he said.
"A total of 530 suspected cases have been
reported, including 48 that have been confirmed by lab testing.
"A total of 172 deaths have been reported
out of those 530 suspected cases."
He said sample testing was ongoing through
national reference laboratories.
The spokesman said Nigerian national and state
authorities were focused on the Covid-19 pandemic response, limiting the human
resources required to conduct investigations and response activities for the
yellow fever outbreaks.
Capacity has been increased in certain
hospitals to help manage patients who develop yellow fever symptoms and
complications.
Currently, 16 of Nigeria's 36 states and the
federal capital territory have completed vaccination campaigns.
Six more are expected to do so in the first
quarter of 2021, with a further six set to do so by the end of next year,
bringing the total to 28, the WHO said.
The percentage of people immunised against
yellow fever remains low in many parts of Africa, even though the vaccine is
nearly 100 per cent effective and relatively cheap.
There is no specific treatment for yellow
fever, which is largely transmitted in urban settings by mosquitoes.
Nigeria, like the rest of Africa, has so far
been spared the brunt of the coronavirus pandemic but authorities are wary of a
fresh wave.
So far, more than 68,300 cases of Covid-19
have been registered, and 1,179 deaths.
Saturday, June 6, 2020
Brazil’s president, Bolsonaro, threatens to cut ties with WHO
![]() |
| Brazilian President Jair Bolsonaro. PHOTO: EVARISTO SA/AFP/Getty Images |
President Jair Bolsonaro threatened Friday to withdraw Brazil from the World
Health Organization, following in the footsteps of his US counterpart, Donald
Trump, accusing it of “ideological bias.”
“I’m telling you right now, the
United States left the WHO, and we’re studying that, in the future. Either the
WHO works without ideological bias, or we leave, too,” the far-right leader
told journalists outside the presidential palace.
Sometimes called a “Tropical Trump,” Bolsonaro has followed a similar script to
the US president in his handling of the coronavirus pandemic, downplaying its
severity, criticizing state authorities’ stay-at-home measures and touting the
purported effects of the drugs chloroquine and hydroxychloroquine against
COVID-19.
Trump announced a week ago he was terminating the United States’
relationship with the WHO, accusing it of bias in favor of China, with whom his
administration has clashed over the origin and handling of the pandemic.
Bolsonaro said it was no coincidence that days later, the WHO reversed its
decision to suspend clinical testing of hydroxychloroquine for COVID-19. The
WHO had suspended trials of the drug after major studies raised concerns about
its safety and effectiveness against the new coronavirus — irking Trump, a
hydroxychloroquine fan who even took the drug himself as a preventive measure.
On Thursday, most of the authors of the studies that appeared in The Lancet and
the New England Journal of Medicine retracted their work, saying they could no
longer vouch for their data after the firm that supplied it refused to be
audited. The WHO has resumed trials of the drug, which is traditionally used
against auto-immune diseases and malaria.
Bolsonaro, however, put the reversal down to the WHO losing its more than $400-million annual contribution from the United States, its biggest funder.
“Trump cut their cash, and they back-tracked on everything,” he said. “Chloroquine is back.” He made the statements shortly before Brazil announced its death toll in the coronavirus pandemic had risen above 35,000 — though, in a change of format, the health ministry stopped reporting the total number of people killed, providing only the figure for the past 24 hours. Brazil has the third-highest death toll in the pandemic, after the US and Britain.
The country of 212 million people has now confirmed more
than 645,000 cases of the virus. Experts say under-testing means the real
numbers are probably far higher.
[AFP]
Wear face masks in public, says WHO in new coronavirus advice
The World Health Organisation Friday changed its advice on face masks amid the
coronavirus pandemic, saying they should be worn in places where the virus is
widespread and physical distancing is difficult.
The use of face masks has been a hot topic ever since the pandemic first
emerged in China in December. “In light of evolving evidence, WHO advises that
governments should encourage the general public to wear face masks where there
is widespread transmission and physical distancing is difficult,” said WHO
chief Tedros Adhanom Ghebreyesus.
In areas with community-level virus transmission, “we advise that people aged 60 years or over, or those with underlying conditions, should wear a medical mask in situations where physical distancing is not possible”, he added.
But the UN health agency stressed that
facemasks alone “will not protect you from COVID-19” — and people suffering
with the virus should not be out in public if they can avoid it. The WHO
maintained its recommendation that people who are sick with COVID-19 symptoms
should stay at home and if it is absolutely necessary for them or their
contacts to leave home, they should wear a medical mask. As before, those
caring for an infected person at home should wear a medical mask when in the
same room; and health workers should wear medical masks plus protective
equipment when dealing with suspected or confirmed COVID-19 patients.
But in an update affecting healthcare workers, the WHO now recommends that in
areas with widespread virus transmission, all people working in clinical sections
of a health facility should wear medical masks — not just those dealing with
patients with COVID-19.
– Three-layer facemask –
The WHO also issued new guidance on the composition of non-medical fabric masks for the general public, advising that they should consist of at least three layers of different material. The inner layer should be made of a water-absorbent material such as cotton, the middle layer — which acts as a filter — from a material like non-woven polypropylene, while the outer layer should be a water-resistant material such as polyester.
The WHO’s emergencies director Michael Ryan stressed that putting on a fabric mask is primarily about preventing the wearer from possibly infecting others, rather than self-protection. “It’s an altruistic act,” he said. And Tedros stressed that masks were only one part of an effective strategy to suppress the virus — and should not lure people into a false sense of security. He said they were not a replacement for physical distancing and hand hygiene.
“Find, isolate, test and care for every case, and to trace and quarantine every contact. That is what we know works. That is every country’s best defence against COVID-19.” The novel coronavirus has infected at least 6.7 million people and killed more than 390,000 since the outbreak first emerged in China last December, according to a tally from official sources compiled by AFP.
[AFP]
Wednesday, June 3, 2020
WHO to resume chloroquine coronavirus clinical trials
The World Health Organisation (WHO) announced Wednesday that clinical trials of the drug hydroxychloroquine will resume as it searches for potential coronavirus treatments.
On May 25, the WHO announced it had temporarily suspended the trials to conduct a safety review, which has now concluded there is “no reason” to change the way the trials are conducted.
The UN health agency’s decision came after a study published in The Lancet medical journal suggesting the drug could increase the risk of death among COVID-19 patients.
The executive group of the so-called Solidarity Trial — in which hundreds of hospitals across the world have enrolled patients to test several possible treatments for the novel coronavirus — took the decision as a precaution.
Hydroxychloroquine is normally used to treat arthritis but public figures including US President Donald Trump have backed the drug for COVID-19 prevention and treatment, prompting governments to bulk-buy.
“Last week, the executive group of the Solidarity Trial decided to implement a temporary pause of the hydroxychloroquine arm of the trial, because of concerns raised about the safety of the drug,” WHO chief Tedros Adhanom Ghebreyesus told a virtual news briefing.
“This decision was taken as a precaution while the safety data were reviewed.
“The data safety and monitoring committee of the Solidarity Trial has been reviewing the data.
“On the basis of the available mortality data, the members of the committee recommended that there are no reasons to modify the trial protocol.
“The executive group received this recommendation and endorsed continuation of all arms of the Solidarity Trial, including hydroxychloroquine.
“The executive group will communicate with the principal investigators in the trial about resuming the hydroxychloroquine arm of the trial.
“The data safety and monitoring committee will continue to closely monitor the safety of all therapeutics being tested in the Solidarity Trial.”
More than 3,500 patients have been recruited across 35 countries to take part in the trials.
[AFP]
Saturday, May 16, 2020
WHO warns coronavirus could kill thousands in Africa, as Burundi expels experts
Highest-risk countries
Action must be taken now
WHO expelled from Burundi
Thanks for reading. Follow the page and Share it.
Thursday, May 14, 2020
Burundi orders WHO team responsible for managing COVID-19 to leave country
Monday, May 4, 2020
WHO says no proof from US on ‘speculative’ Wuhan lab virus claims
The World Health Organisation, WHO, said Monday that Washington had provided no evidence to support “speculative” claims by the US president that the new coronavirus originated in a lab in the Chinese city of Wuhan.
“We have not received any data or specific evidence from the United States government relating to the purported origin of the virus, so from our perspective this remains speculative,” WHO emergencies director Michael Ryan told a virtual briefing.
[AFP]
Saturday, March 14, 2020
Coronavirus kills 5,000, hits 123 countries, 132,000 cases – WHO
Thanks for reading. Follow the page and Share it.
Sunday, January 26, 2020
Coronavirus: WHO puts Nigeria, others on alert as death toll hits 56
Thanks for reading. Follow the page and Share it.
Wednesday, January 22, 2020
WHO postpones decision on declaring coronavirus as global health emergency
Thanks for reading. Follow the page and Share it.
Thursday, September 12, 2019
Ghana Health Service and Partners launch polio vaccination campaigns in Ghana
![]() |
Country Representative of WHO, Dr Owen Kaluwa vaccinating a baby
|












